LBSP Favicon

LED3 Lecture: Synthetic Biology for Drug Discovery

The Leiden Early Drug Discovery & Development (LED3) network is a collaboration between Leiden University’s Institute of Biology (IBL), Leiden Institute of Chemistry (LIC), and the Leiden Academic Centre for Drug Research (LACDR).

LED3 drives the discovery of innovative drug targets, molecules, and concepts to develop safer, more effective treatments for diseases like cancer, cardiovascular, neurodegenerative, and infectious conditions.

By combining expertise across early drug discovery stages, LED3 enhances understanding of molecular and cellular interactions, advancing novel approaches to drug development.

Located near the Leiden Bio Science Park and LUMC, LED3 partners with academia and industry to accelerate drug discovery and development.

Join a lecture by Professor Jay Keasling, a world-renowned leader in synthetic biology and metabolic engineering from the University of California, Berkeley.

This lecture will delve into how synthetic biology can revolutionize drug discovery and development, highlighting its potential to address global challenges like climate change, healthcare inequality, and resource scarcity.

Details